Insulet (PODD) FY2015 results: revenue $264 million, up 14.1% on the year
Insulet Corp. (PODD) reported revenue of $264 million for fiscal 2015, the year ended 31 December 2015, up 14.1% on the year before. Net income was -$74 million, and diluted earnings per share $-1.29. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2017.
Revenue
$264 million
+14.1% on the year
FY2009FY2015
Operating margin
-18.5%
-3.8% a year earlier
FY2009FY2015
Net income
-$74 million
FY2009FY2015
Diluted EPS
-$1.29
FY2009FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
264
231
185
+14.1%
Cost of revenue
131
104
95.4
+25.4%
Gross profit
133
127
89.8
+4.8%
Gross margin
50.5%
55.0%
48.5%
Research and development
43.2
27.9
21.8
+54.9%
Operating income
-48.7
-8.9
-26.7
Operating margin
-18.5%
-3.8%
-14.4%
Interest expense
12.7
14.6
16.9
-12.8%
Pre-tax income
-61.4
-47.9
-42.5
Income tax
0.2
0.1
0.0
+253.3%
Net income
-73.5
-51.5
-45.0
Net margin
-27.9%
-22.3%
-24.3%
Diluted EPS
-$1.29
-$0.93
-$0.83
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
-12.6
8.9
3.3
Capital expenditure
10.6
11.5
7.3
-7.6%
Free cash flow
-23.2
-2.6
-4.0
Free cash flow margin
-8.8%
-1.1%
-2.1%
Cash from investing
-15.3
-11.5
-7.3
Cash from financing
-0.4
4.0
96.4
Depreciation and amortisation
15.8
12.2
11.8
+29.6%
Share-based compensation
19.2
22.5
12.7
-14.8%
Shares outstanding at period end
57m
56m
55m
+1.1%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
34.1
83.8
125
-59.4%
Debt
172
164
114
+4.7%
Other liabilities
69.4
49.3
49.7
+40.6%
Total liabilities and equity
275
297
288
-7.4%
Fixed assets
41.8
36.9
32.4
+13.1%
Goodwill
39.6
37.4
37.4
+5.9%
Intangible assets
0.9
0.0
18.0
Investments
0.0
n/a
n/a
Cash and equivalents
123
151
150
-18.9%
Receivables
42.5
35.2
33.1
+20.7%
Inventory
12.0
11.4
9.5
+5.0%
Other assets
15.6
25.0
7.9
-37.6%
Total assets
275
297
288
-7.4%
10-K for the year ended 31 December 2015, filed 28 February 2017: the filing.